Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ALT Altimmune	$3.54 +0.3%	$4.44	$2.90 ▼ $11.16	$311.55M	-0.01	2.90 million shs	2.83 million shs
CKT Cricket Media Group		C$0.00	C$0.07 ▼ C$0.32	N/A	N/A	607 shs	N/A
CRDL Cardiol Therapeutics	$1.17	$1.31	$0.77 ▼ $2.63	$97.94M	1.05	1.34 million shs	1.35 million shs
TIDE Tidelands Oil & Gas		$0.00	$0.00 ▼ $0.00	N/A	14.34	600 shs	N/A

7 Stocks to Buy And Hold Forever

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ALT Altimmune	+0.28%	-2.48%	-17.48%	-38.00%	-48.47%
CRDL Cardiol Therapeutics	0.00%	-10.69%	-18.75%	+6.36%	-42.65%
TIDE Tidelands Oil & Gas	0.00%	0.00%	0.00%	0.00%	0.00%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ALT Altimmune	3.2571 of 5 stars	4.3	3.0	0.0	0.0	1.9	1.7	0.6
CKT Cricket Media Group	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CRDL Cardiol Therapeutics	2.5891 of 5 stars	3.7	2.0	0.0	0.0	3.9	0.0	0.6
TIDE Tidelands Oil & Gas	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ALT Altimmune	2.57	Moderate Buy	$17.40	391.53% Upside
CKT Cricket Media Group	0.00	N/A	N/A	N/A
CRDL Cardiol Therapeutics	3.33	Buy	$8.00	583.76% Upside
TIDE Tidelands Oil & Gas	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest TIDE, CRDL, ALT, and CKT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/13/2025	ALT Altimmune	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$12.00
8/13/2025	ALT Altimmune	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$26.00 ➝ $24.00
8/13/2025	ALT Altimmune	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$20.00 ➝ $18.00
7/10/2025	ALT Altimmune	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong Sell
7/10/2025	ALT Altimmune	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Market Outperform ➝ Market Outperform	$25.00 ➝ $15.00
6/27/2025	ALT Altimmune	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Perform ➝ Market Perform
6/27/2025	ALT Altimmune	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$12.00
6/2/2025	CRDL Cardiol Therapeutics	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$9.00

(Data available from 8/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ALT Altimmune	$20K	15,621.49	N/A	N/A	$1.83 per share	1.93
CKT Cricket Media Group	N/A	N/A	N/A	N/A	N/A	N/A
CRDL Cardiol Therapeutics	N/A	N/A	N/A	N/A	$0.10 per share	N/A
TIDE Tidelands Oil & Gas	N/A	N/A	N/A	N/A	N/A	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ALT Altimmune	-$95.06M	-$1.18	N/A	N/A	N/A	-438,730.03%	-62.63%	-55.29%	11/11/2025 (Estimated)
CKT Cricket Media Group	N/A	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A
CRDL Cardiol Therapeutics	-$26.77M	-$0.34	N/A	N/A	N/A	N/A	-232.26%	-158.19%	N/A
TIDE Tidelands Oil & Gas	N/A	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A

Latest TIDE, CRDL, ALT, and CKT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/14/2025	Q2 2025	CRDL Cardiol Therapeutics	-$0.11	-$0.07	+$0.04	-$0.07	N/A	N/A
8/12/2025	Q2 2025	ALT Altimmune	-$0.32	-$0.27	+$0.05	-$0.27	$0.00 million	$0.01 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ALT Altimmune	N/A	N/A	N/A	N/A	N/A
CKT Cricket Media Group	N/A	N/A	N/A	N/A	N/A
CRDL Cardiol Therapeutics	N/A	N/A	N/A	N/A	N/A
TIDE Tidelands Oil & Gas	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ALT Altimmune	0.09	20.44	20.44
CKT Cricket Media Group	N/A	N/A	N/A
CRDL Cardiol Therapeutics	0.01	2.46	3.26
TIDE Tidelands Oil & Gas	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ALT Altimmune	78.05%
CKT Cricket Media Group	N/A
CRDL Cardiol Therapeutics	12.49%
TIDE Tidelands Oil & Gas	N/A

Insider Ownership

Company	Insider Ownership
ALT Altimmune	4.10%
CKT Cricket Media Group	N/A
CRDL Cardiol Therapeutics	5.25%
TIDE Tidelands Oil & Gas	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ALT Altimmune	50	88.26 million	84.64 million	Optionable
CKT Cricket Media Group	147,000	N/A	N/A	Not Optionable
CRDL Cardiol Therapeutics	20	83.71 million	79.32 million	Not Optionable
TIDE Tidelands Oil & Gas	6	N/A	N/A	Not Optionable

TIDE, CRDL, ALT, and CKT Headlines

Recent News About These Companies

No headlines for this company have been tracked by MarketBeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

TIDE, CRDL, ALT, and CKT Company Descriptions

Altimmune NASDAQ:ALT

$3.54 +0.01 (+0.28%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$3.54 0.00 (-0.14%)

As of 08/22/2025 07:59 PM Eastern

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and metabolic dysfunction-associated steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.

Cricket Media Group CVE:CKT

Cricket Media Group Ltd. (Cricket Media) is a United States-based education media company. The Company provides content on a learning network for children, families and teachers across the world. Its media brands for toddlers to teens include Babybug, Ladybug, Cricket and Cobblestone. The Company's products include magazines under categories, such as Ask, Cicada, Babybug, Click, Cricket, Cobblestone, Dig, Faces, Ladybug, Muse and Spider; educational toys; books; teacher guides; content library, and Story Bug application. Its Web-based K12 tools for school and home include the ePals community and virtual classroom for global collaboration, as well as In2Books, a Common Core eMentoring program that builds reading, writing and critical thinking skills. It serves teachers, students and parents in over 200 countries and territories through its platform and NeuPals, its joint venture with China-based information technology services company Neusoft.

Cardiol Therapeutics NASDAQ:CRDL

$1.17 0.00 (0.00%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$1.17 0.00 (-0.09%)

As of 08/22/2025 07:56 PM Eastern

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.

Tidelands Oil & Gas OTCMKTS:TIDE

Tidelands Oil & Gas Corporation engages in the development and operation of transportation and storage infrastructure for natural gas in South Texas and the Northern Mexican states of Tamaulipas and Nuevo Leon. It also offers receipt and regasification of liquefied natural gas in the offshore waters of Southern California. The company was formerly known as C2 Technologies, Inc. and changed its name to Tidelands Oil & Gas Corporation in November 1998. Tidelands Oil & Gas Corporation was founded in 1997 and is based in San Antonio, Texas.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time